Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2007
04/26/2007WO2007046867A2 Piperidine derivatives and their uses as therapeutic agents
04/26/2007WO2007046775A1 Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
04/26/2007WO2007046703A2 Improved aav vectors produced in insect cells
04/26/2007WO2007046556A1 Novel dna polymerase
04/26/2007WO2007046439A1 Transgenic silkworm capable of producing antibody and method for production thereof
04/26/2007WO2007046417A1 METHOD OF CONVERTING L-ARABINOSE INTO α-KETOGLUTARIC ACID, ENZYMES TO BE USED IN THE METHOD, GENES ENCODING THE ENZYMES AND RECOMBINANT MICROORGANISM CONTAINING THE GENES
04/26/2007WO2007046403A1 Plant belonging to genus oryza having dominant dwarf trait, and use thereof
04/26/2007WO2007046398A1 Stem cell-specific promoter
04/26/2007WO2007046148A1 Novel aromatic acyl group transferase gene
04/26/2007WO2007045691A2 Renal carcinoma cell line and use thereof
04/26/2007WO2007045690A1 Recombinant cell lines for the stable and high-level production of biologically active dkk1 protein
04/26/2007WO2007045661A1 Detection or quantification of aggrecan and its fragments
04/26/2007WO2007045616A1 Thermoset particles and methods for production thereof
04/26/2007WO2007028243B1 An embedding method and apparatus for the preparation of frozen section tissue
04/26/2007WO2007027226A3 Systems and methods for the production of differentiated cells
04/26/2007WO2007005659A3 Methods and compositions for culturing keratinocytes
04/26/2007WO2007000671A3 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells
04/26/2007WO2006121422A8 Antibodies against clostridium difficile toxins and uses thereof
04/26/2007WO2006044204A3 Neuronal progenitors from feeder-free human embryonic stem cell culture
04/26/2007WO2006018312A9 Washing apparatus
04/26/2007WO2005091777A3 Methods and materials relating to insulin growth factor-like (igfl) polypeptides and polynucleotides
04/26/2007WO2005054808A3 Method for sex biasing spermatozoa
04/26/2007WO2005041859A3 Conjugates and compositions for cellular delivery.
04/26/2007WO2003095359A3 Nanotube mat with an array of conduits
04/26/2007US20070094751 Altered metabolism
04/26/2007US20070094749 Method for producing ketocarotinoids in plant fruit
04/26/2007US20070094748 Recombinant DNA constructs and methods for controlling gene expression
04/26/2007US20070094747 Inbred Corn Line PHCAM
04/26/2007US20070094746 Hybrid caulimovirus promoters and constructs thereof
04/26/2007US20070094745 Cotton cultivar DP 164 B2RF
04/26/2007US20070094743 ABCG1/ABCG4-related methods and compositions
04/26/2007US20070093445 RNA interference mediating small RNA molecules
04/26/2007US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent
04/26/2007US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2
04/26/2007US20070092967 improve a success rate of cell culture up, by adding an anticoagulant to the blood, diluting with an alpha-minimum essential medium, then centrifugation to harvest monocytes, culturing in an alpha-minimum essential medium with other growth factors; used for cell therapy
04/26/2007US20070092966 In Vitro Tumor Angiogenesis Model
04/26/2007US20070092965 Isolating a mammalian conjunctival tissue explant in a growth medium until nodules form, allowing cells to grow; for treating lacerated corneas, ocular cicatricial pemphigoid, Steven Johnson syndrome, alkali burns and neurotrophic keratitis; kits for detecting mucin deficiency
04/26/2007US20070092958 Method and apparatus for guiding growth of neurons
04/26/2007US20070092948 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells
04/26/2007US20070092947 Methods and compositions for increasing longevity and protein yield from a cell culture
04/26/2007US20070092941 PRO1298 polypeptides
04/26/2007US20070092933 Production of multimeric fusion proteins using a c4bp scaffold
04/26/2007US20070092918 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer
04/26/2007US20070092912 Uses of human zven antagonists
04/26/2007US20070092898 Detection of multiple anti-viral antibodies
04/26/2007US20070092861 Environments that maintain function of primary liver cells
04/26/2007US20070092860 cryopreserving sperm that have been selected for a specific characteristic; for artificial insemination or in vitro fertilization
04/26/2007US20070092550 Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
04/26/2007US20070092538 Immunogenic reagents from west nile virus
04/26/2007US20070092521 producing a glycosylated monoclonal antibody or Fc fusion protein by culturing the cell in the presence of kifunensine ; for targeted killing of cells in a mammal, including therapeutic methods of treating cancers, autoimmune diseases and other diseases
04/26/2007US20070092520 Humanized Anti-CMET Antagonists
04/26/2007US20070092516 Antibody preparation
04/26/2007US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
04/26/2007US20070092504 Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses
04/26/2007US20070092497 Cytotherapeutics, cytotherapeutic units and methods for treatments using them
04/26/2007US20070092496 Method of delivering cells to the skin
04/26/2007US20070092495 Methods for regulating differentiation of neural cells and uses thereof
04/26/2007US20070092493 Living cell sheet
04/26/2007US20070092492 Three-dimentional tissue structure
04/26/2007US20070092490 High efficiency sin vector
04/26/2007US20070092486 Glycolated and glycosylated poultry derived therapeutic proteins
04/26/2007DE102005050723A1 Verfahren zur Aufbereitung der unbefruchteten Eier von Wassertieren zu Delikatess-Nahrungsmitteln und mit dem Verfahren aufbereitete Eier Process for the preparation of the unfertilized eggs of aquatic animals delicatessen food and prepared by the method of eggs
04/26/2007CA2856662A1 Immunomodulation using placental stem cells
04/26/2007CA2626642A1 Parthenogenic activation of human oocytes for the production of human embryonic stem cells
04/26/2007CA2626525A1 Conditionally immortalized long-term stem cells and methods of making and using such cells
04/26/2007CA2626356A1 Modified proteases that inhibit complement activation
04/26/2007CA2626199A1 Method of delivering hair follicle progenitor cells to the skin
04/26/2007CA2625891A1 Inhibition of pax2 by defb1 induction as a therapy for cancer
04/26/2007CA2625883A1 Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
04/26/2007CA2625848A1 Resorbable cornea button
04/26/2007CA2625619A1 Cell display of antibody libraries
04/26/2007CA2625169A1 Methods of reducing repeat-induced silencing of transgene expression and improved fluorescent biosensors
04/26/2007CA2624925A1 Immunomodulation using placental stem cells
04/26/2007CA2624916A1 Production of oligodendrocytes from placenta-derived stem cells
04/26/2007CA2624906A1 Thermoset particles and methods for production thereof
04/26/2007CA2622233A1 Improved aav vectors produced in insect cells
04/25/2007EP1777293A1 Transferrin receptor genes of Moraxella
04/25/2007EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
04/25/2007EP1776583A2 Methods for preparing t-cells for cell therapy
04/25/2007EP1776454A2 Organogenesis from dissociated cells
04/25/2007EP1776453A1 Isolation of endothelial progenitor cell subsets and methods for their use
04/25/2007EP1776452A1 Washing apparatus
04/25/2007EP1776386A1 Anti-ghrelin antibodies
04/25/2007EP1776384A2 Variant fc regions
04/25/2007EP1776383A2 Binding molecules
04/25/2007EP1776141A2 Dendritic cell vaccines for treating cancer made from embryonic stem cells
04/25/2007EP1776126A2 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
04/25/2007EP1589814A4 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
04/25/2007EP1584232B1 Sigma receptor-deficient, mutant, non-human mammals and applications thereof
04/25/2007EP1476463B1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
04/25/2007EP1434852B1 A universal light-switchable gene promoter system
04/25/2007EP1430133B1 A soluble toll-like receptor
04/25/2007EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b
04/25/2007EP1416888A4 Meniscus regeneration device and method
04/25/2007EP1416879A4 Unitary surgical device and method
04/25/2007EP1368467B1 Putrescine-n-methyltransferase promoter
04/25/2007EP1320542B1 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
04/25/2007EP1309626B1 Cng2b: a putative human cyclic nucleotide-gated ion channel
04/25/2007EP1294888B1 Interferon-like protein zcyto21
04/25/2007EP1254174B1 Human cyr61